Late last month, Utah’s Medical Licensing Board called for the immediate suspension of the state’s pilot program with the AI company Doctronic.
The program permitted a chatbot to evaluate patients and recommend prescription renewals for nearly 200 chronic condition drugs, with the state planning to phase out physician review of each case.
The board stated that it only became aware of the pilot after its launch. Its warning was unequivocal:
Proceeding without proper clinical oversight potentially places Utah citizens at risk.
The move highlights growing concerns over the regulation of AI in healthcare and the need for structured licensing frameworks to ensure patient safety.
Related articles
Supreme Court Blocks Restrictions on Abortion Pill Mifepristone, Ensuring Continued Access
WASHINGTON — The Supreme Court on Thursday preserved women’s access to a drug used in the most common method of abortion, rejecting lower-court restri...
Study Links High Air Pollution to Increased Post-Surgical Complications on Utah’s Wasatch Front
New research on Utah’s Wasatch Front—which occasionally experiences the worst air quality in the nation—has found an association between high air poll...
BeOne Secures FDA Approval for Novel Lymphoma Cell Therapy, Advancing Autoimmune Treatment Pipeline
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Biotech’s cell therapy boo...
Why Major Digital Health Companies Are Absent from Medicare’s Chronic Care Pilot Program
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it deli...
Biogen’s Tau-Targeting Alzheimer’s Drug Shows Promise in Mid-Stage Trial
Biogen reported mixed results Thursday from a mid-stage clinical trial investigating a treatment for Alzheimer’s disease that targets the protein tau...
Kyle Diamantas Named Acting FDA Commissioner Amid Biotech Sector Optimism
This is the online version of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their...
Alcohol Addiction Treatment: A Paradigm Shift in Recovery Approaches
All Jillian wanted was to regain control of her drinking. At 38, she knew alcohol had already cost her a marriage and begun to threaten her career. Wh...
AI in Addiction Medicine: Balancing Innovation with Human Connection
Recently, I saw one version of the AI-enabled future of medicine. It was compelling in its simplicity, thrilling in its potential as a force multiplie...